Chapter 2: Pathophysiology of neurogenic detrusor overactivity and the symptom complex of “Overactive bladder”

Relationship between overactive bladder (OAB) and irritable bowel syndrome (IBS): concurrent disorders with a common pathophysiology?

(2013) Donna Daly et al.   BJU INTERNATIONAL

Involvement of Connexins 43 and 45 in Functional Mechanism of Human Detrusor Overactivity in Neurogenic Bladder

(2013) Véronique Phé et al.   UROLOGY

Relationship between overactive bladder and irritable bowel syndrome: a large-scale internet survey in Japan using the overactive bladder symptom score and Rome III criteria

(2012) Seiji Matsumoto et al.   BJU INTERNATIONAL

A Systematic Review and Meta-analysis on the Use of Phosphodiesterase 5 Inhibitors Alone or in Combination with α-Blockers for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia

(2012) Mauro Gacci et al.   EUROPEAN UROLOGY

Botulinum Neurotoxin Serotype A Suppresses Neurotransmitter Release from Afferent as Well as Efferent Nerves in the Urinary Bladder

(2012) Youko Ikeda et al.   EUROPEAN UROLOGY

Effects of Mirabegron, a Novel β3-Adrenoceptor Agonist, on Primary Bladder Afferent Activity and Bladder Microcontractions in Rats Compared With the Effects of Oxybutynin

(2012) Naoki Aizawa et al.   EUROPEAN UROLOGY

Pathophysiology of overactive bladder

(2012) Mai A. Banakhar et al.   INTERNATIONAL UROGYNECOLOGY JOURNAL

Urinary Neurotrophic Factors in Healthy Individuals and Patients with Overactive Bladder

(2012) Tiago Antunes-Lopes et al.   JOURNAL OF UROLOGY

Mechanisms of action of botulinum neurotoxins, β3-adrenergic receptor agonists, and PDE5 inhibitors in modulating detrusor function in overactive bladders: ICI-RS 2011

(2012) Anthony Kanai et al.   NEUROUROLOGY AND URODYNAMICS

Insight into New Potential Targets for the Treatment of Overactive Bladder and Detrusor Overactivity

(2012) M.A. Cerruto et al.   UROLOGIA INTERNATIONALIS

Researching bladder afferents-determining the effects of β3-adrenergic receptor agonists and botulinum toxin type-A

(2011) Anthony Kanai et al.   NEUROUROLOGY AND URODYNAMICS

Rodent models for urodynamic investigation

(2011) Karl-Erik Andersson et al.   NEUROUROLOGY AND URODYNAMICS

Vardenafil Decreases Bladder Afferent Nerve Activity in Unanesthetized, Decerebrate, Spinal Cord–Injured Rats

(2010) Delphine Behr-Roussel et al.   EUROPEAN UROLOGY

Basic Mechanisms of Urgency: Preclinical and Clinical Evidence

(2009) Martin C. Michel et al.   EUROPEAN UROLOGY

In Vitro Release of Adenosine Triphosphate from the Urothelium of Human Bladders with Detrusor Overactivity, Both Neurogenic and Idiopathic

(2009) Vivek Kumar et al.   EUROPEAN UROLOGY

Spontaneous Contractions Evoke Afferent Nerve Firing in Mouse Bladders With Detrusor Overactivity

(2009) Carly J. McCarthy et al.   JOURNAL OF UROLOGY

Fourth international consultation on incontinence recommendations of the international scientific committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence

(2009) P. Abrams et al.   NEUROUROLOGY AND URODYNAMICS

Basic mechanisms of urgency: roles and benefits of pharmacotherapy

(2009) Martin Christian Michel et al.   WORLD JOURNAL OF UROLOGY

Suburothelial Myofibroblasts in the Human Overactive Bladder and the Effect of Botulinum Neurotoxin Type A Treatment

(2008) Alexander Roosen et al.   EUROPEAN UROLOGY

Urinary Nerve Growth Factor Levels are Elevated in Patients with Detrusor Overactivity and Decreased in Responders to Detrusor Botulinum Toxin-A Injection

(2008) Hsin-Tzu Liu et al.   EUROPEAN UROLOGY

Basic and Clinical Aspects of Non-neuronal Acetylcholine: Expression of Non-neuronal Acetylcholine in Urothelium and Its Clinical Significance

(2008) Masaki Yoshida et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

The neural control of micturition

(2008) Clare J. Fowler et al.   NATURE REVIEWS NEUROSCIENCE